Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 6 | 2024 | 74 | 1.460 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 4 | 2019 | 32 | 1.310 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2024 | 719 | 1.290 |
Why?
|
| Serine-Arginine Splicing Factors | 2 | 2019 | 14 | 0.760 |
Why?
|
| Carcinogenesis | 2 | 2021 | 130 | 0.740 |
Why?
|
| Carcinoma, Papillary | 2 | 2020 | 36 | 0.720 |
Why?
|
| RNA Splicing | 2 | 2019 | 162 | 0.720 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 9 | 0.690 |
Why?
|
| Transcriptome | 2 | 2021 | 387 | 0.640 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 309 | 0.630 |
Why?
|
| Alternative Splicing | 4 | 2018 | 127 | 0.620 |
Why?
|
| Repressor Proteins | 1 | 2020 | 346 | 0.550 |
Why?
|
| DNA Damage | 3 | 2015 | 287 | 0.440 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 778 | 0.410 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 1469 | 0.400 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 491 | 0.400 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 435 | 0.360 |
Why?
|
| Genome-Wide Association Study | 4 | 2021 | 359 | 0.350 |
Why?
|
| Haplotypes | 2 | 2020 | 131 | 0.320 |
Why?
|
| Genotype | 3 | 2020 | 663 | 0.320 |
Why?
|
| Alleles | 2 | 2020 | 448 | 0.300 |
Why?
|
| Rhabdomyosarcoma | 2 | 2015 | 16 | 0.220 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 45 | 0.200 |
Why?
|
| Protein Interaction Maps | 2 | 2020 | 35 | 0.190 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2021 | 1 | 0.180 |
Why?
|
| Spectrin | 1 | 2021 | 8 | 0.180 |
Why?
|
| RNA Splice Sites | 1 | 2021 | 23 | 0.180 |
Why?
|
| Thyroid Gland | 1 | 2021 | 81 | 0.170 |
Why?
|
| Telomere-Binding Proteins | 1 | 2020 | 6 | 0.160 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2020 | 6 | 0.160 |
Why?
|
| Linkage Disequilibrium | 1 | 2020 | 47 | 0.160 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 81 | 0.160 |
Why?
|
| Telomere | 1 | 2020 | 52 | 0.160 |
Why?
|
| Humans | 14 | 2024 | 63443 | 0.150 |
Why?
|
| Mutation, Missense | 1 | 2020 | 186 | 0.150 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2018 | 38 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 130 | 0.140 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 507 | 0.140 |
Why?
|
| Pedigree | 3 | 2024 | 193 | 0.130 |
Why?
|
| Photoreceptor Cells | 1 | 2016 | 19 | 0.130 |
Why?
|
| Xenopus Proteins | 1 | 2016 | 35 | 0.130 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 38 | 0.130 |
Why?
|
| Eye Proteins | 1 | 2016 | 74 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2014 | 197 | 0.130 |
Why?
|
| Melanoma | 1 | 2020 | 331 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2015 | 191 | 0.120 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2015 | 9 | 0.120 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2015 | 16 | 0.120 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 268 | 0.120 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 69 | 0.110 |
Why?
|
| Exons | 1 | 2015 | 199 | 0.110 |
Why?
|
| HeLa Cells | 1 | 2015 | 536 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 642 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 325 | 0.090 |
Why?
|
| Middle Aged | 6 | 2024 | 17612 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2016 | 1513 | 0.070 |
Why?
|
| Male | 7 | 2024 | 29889 | 0.070 |
Why?
|
| Female | 7 | 2024 | 32878 | 0.070 |
Why?
|
| Adult | 5 | 2024 | 16823 | 0.070 |
Why?
|
| Animals | 3 | 2019 | 20663 | 0.060 |
Why?
|
| Mice | 1 | 2019 | 10844 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2014 | 3035 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2021 | 988 | 0.050 |
Why?
|
| Mutation | 2 | 2021 | 2612 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2021 | 65 | 0.040 |
Why?
|
| Pacific Islands | 1 | 2021 | 4 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2021 | 123 | 0.040 |
Why?
|
| Heterozygote | 1 | 2021 | 170 | 0.040 |
Why?
|
| Chromosomes, Human | 1 | 2021 | 52 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 14446 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 281 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5462 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 356 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 81 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 525 | 0.040 |
Why?
|
| RNA Precursors | 1 | 2018 | 76 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1119 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 770 | 0.030 |
Why?
|
| Phenotype | 1 | 2021 | 1207 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 2016 | 25 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2016 | 24 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 65 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2016 | 67 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 477 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2016 | 216 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 363 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1079 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 517 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 47 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 676 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2014 | 176 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 190 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2013 | 209 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 878 | 0.020 |
Why?
|
| Child | 1 | 2021 | 4526 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 2187 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 396 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1537 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 6245 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 1364 | 0.010 |
Why?
|